Risk factors for recurrent cardiovascular events in CKD: results from the KNOW-CKD study
Journal of Nephrology · 30.10.2026 · 39 (8) · 1616-1625
DOI: 10.1093/joneph/aajag150 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Nephrology, online erschienen am 14.08.2026. Verfasst von Eunjeong Kang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Transplantation Center, Seoul National University Hospital, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Cardiovascular Diseases. Die Arbeit nennt 30 Literaturangaben. Gefördert von: National Institute of Health.
Abstract (Originalsprache)
Background
Chronic kidney disease (CKD) markedly increases cardiovascular (CV) risk, and some patients experience recurrent CV events over time. Analyses restricted to time-to-first event may therefore underestimate the total CV burden. We evaluated determinants of both first and recurrent non-fatal CV events in CKD.
Methods
We analyzed 2099 non-dialysis participants with CKD enrolled in the prospective KNOW-CKD cohort. CV events were adjudicated and included myocardial infarction, stroke, heart failure, coronary or peripheral revascularization, and clinically significant arrhythmias. Predictors of the first event were assessed using Cox proportional hazards models. Recurrent-event risk was evaluated using Andersen–Gill, Prentice–Williams–Peterson total-time and gap-time models, and shared-frailty models, complemented by mean cumulative function analyses.
Results
Over a median follow-up of 8.29 years, 203 participants (9.7%) experienced at least one non-fatal CV event (158 had one event, 39 had two, and 6 had three). Participants with baseline CV disease or diabetes exhibited substantially higher cumulative event burdens. Older age, diabetes, prior CV disease, higher C-reactive protein (CRP), albuminuria, and lower body mass index (BMI) were consistently associated with recurrent events across models; CRP and albuminuria showed relatively stronger associations with recurrence than with the first event.
Conclusion
In CKD, recurrent CV risk is driven not only by traditional factors, particularly diabetes, but also by markers of vascular injury and inflammation. Strategies targeting both metabolic and inflammatory pathways may be critical to reducing recurrent CV burden.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Transplantation Center, Seoul National University Hospital, Seoul, Republic of Korea.
- Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
- Department of Internal Medicine, Uijeongbu Eulji Medical Center, Eulji University, Gyeonggi-do, Republic of Korea.
- Division of Nephrology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
- Department of Internal Medicine, College of Medicine, Institute of Kidney Disease Research, Yonsei University, Seoul, Republic of Korea.
- Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Republic of Korea.
ORCID-Profile: Eunjeong Kang, Dah Woon Im, Minsang Kim, Yaeni Kim, Tae-Hyun Yoo, Soo Wan Kim, Jayoun Kim, Kook-Hwan Oh
Förderung
- National Institute of Health
Zitieren
APA
Kang, E., Im, D. W., Kim, M., Kim, Y., Yoo, T. H., Kim, S. W., Kim, J., & Oh, K. H. (2026). Risk factors for recurrent cardiovascular events in CKD: results from the KNOW-CKD study. Journal of Nephrology, 39(8), 1616-1625. https://doi.org/10.1093/joneph/aajag150
Vancouver
Kang E, Im DW, Kim M, Kim Y, Yoo TH, Kim SW, et al. Risk factors for recurrent cardiovascular events in CKD: results from the KNOW-CKD study. Journal of Nephrology. 2026;39(8):1616-1625. doi:10.1093/joneph/aajag150
BibTeX
@article{Kang2026,
author = {Kang, Eunjeong and Im, Dah Woon and Kim, Minsang and Kim, Yaeni and Yoo, Tae-Hyun and Kim, Soo Wan and Kim, Jayoun and Oh, Kook-Hwan},
title = {Risk factors for recurrent cardiovascular events in CKD: results from the KNOW-CKD study},
journal = {Journal of Nephrology},
year = {2026},
volume = {39},
number = {8},
pages = {1616--1625},
doi = {10.1093/joneph/aajag150}
}
EUVIMED